SCA
BIOT

Salient Capital Advisors’s Biotech Acquisition Company Class A Ordinary Shares BIOT Stock Holding History

Salient Capital Advisors’s Portfolio BIOT Stock Details BIOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-32,175
Closed -$317K – 88
2022
Q1 		$317K Hold
32,175
– – 0.01% 56
2021
Q4 		$317K Buy
+32,175
New +$317K 0.02% 63